Neogenomics (NEO) FCF Margin (2010 - 2026)
Neogenomics (NEO) reported FCF Margin of 7.04% for Q1 2026, up 1071.0% on a YoY basis from 0.6% in Q1 2025, and down 171.32% quarter-over-quarter from 9.87% in Q4 2025.
Neogenomics (NEO) FCF Margin (2010 - 2026) Analysis & Trends
Neogenomics has reported FCF Margin for 17 years, with the latest figure at 7.04% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1071.0% year-over-year to 7.04%; the trailing twelve-month figure through Mar 2026 stood at 2.71% (up 157.0% YoY), and the FY2025 full-year result was 0.48%, down 43.0% from the prior year.
- FCF Margin for Q1 2026 stood at 7.04%, down from 9.87% in the prior quarter.
- The five-year high for FCF Margin was 22.24% in Q4 2024, with the low at 31.8% in Q1 2022.
- Historically, FCF Margin has averaged 3.87% across 5 years, with a median of 0.93% in 2024.
- The largest YoY upside for FCF Margin was 4039 bps in 2022 against a maximum downside of 3191 bps in 2022.
- Neogenomics' FCF Margin stood at 15.13% in 2022, then declined by 24 bps to 11.45% in 2023, then soared by 94 bps to 22.24% in 2024, then slumped by 56 bps to 9.87% in 2025, then tumbled by 171 bps to 7.04% in 2026.
- The last three FCF Margin figures came in at 7.04% (Q1 2026), 9.87% (Q4 2025), and 0.3% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -3.31% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 7.41% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 18.23% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 22.61% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 10.95% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 11.83% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 2.59% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 23.01% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 12.92% |
| 10 | Neogenomics | 1.41 Bn | 1.27 Bn | 80.86 Mn | -7.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.04% |
| Dec 31, 2025 | 9.87% |
| Sep 30, 2025 | 0.30% |
| Jun 30, 2025 | 7.72% |
| Mar 31, 2025 | -17.75% |
| Dec 31, 2024 | 22.24% |
| Sep 30, 2024 | -0.93% |
| Jun 30, 2024 | 0.49% |
| Mar 31, 2024 | -20.16% |
| Dec 31, 2023 | 11.45% |
| Sep 30, 2023 | 7.43% |
| Jun 30, 2023 | -12.11% |
| Mar 31, 2023 | -10.10% |
| Dec 31, 2022 | 15.13% |
| Sep 30, 2022 | -18.73% |
| Jun 30, 2022 | -21.82% |
| Mar 31, 2022 | -31.80% |
| Dec 31, 2021 | -25.26% |
| Sep 30, 2021 | -18.74% |
| Jun 30, 2021 | -29.98% |